{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:49:10Z","timestamp":1761598150801,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Macau Science and Technology Development Fund","award":["0029\/2018\/A1"],"award-info":[{"award-number":["0029\/2018\/A1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scientometrics"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11192-019-03313-7","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T06:04:18Z","timestamp":1575439458000},"page":"1113-1128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The gap analysis between Chinese pharmaceutical academia and industry from 2000 to 2018"],"prefix":"10.1007","volume":"122","author":[{"given":"Hao","family":"Zhong","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0050-7111","authenticated-orcid":false,"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"3313_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1057\/9781137034298_7","volume-title":"The Chinese economy","author":"J Banister","year":"2012","unstructured":"Banister, J. (2012). Population aging and economic growth in China. The Chinese economy (pp. 114\u2013149). London: Palgrave Macmillan."},{"issue":"10","key":"3313_CR2","doi-asserted-by":"publisher","first-page":"9594","DOI":"10.1021\/acsnano.7b04855","volume":"11","author":"M Bjornmalm","year":"2017","unstructured":"Bjornmalm, M. (2017). Bridging bio\u2013nano science and cancer nanomedicine. ACS Nano,11(10), 9594\u20139613.","journal-title":"ACS Nano"},{"key":"3313_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2012.09.033","volume":"64","author":"L Brannon-Peppas","year":"2012","unstructured":"Brannon-Peppas, L. (2012). Nanoparticle and targeted systems for cancer therapy. Advanced Drug Delivery Reviews,64, 206\u2013212.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"3","key":"3313_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","volume":"57","author":"C Chaomei","year":"2006","unstructured":"Chaomei, C. (2006). Citespace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for Information Science Technology,57(3), 359\u2013377.","journal-title":"Journal of the American Society for Information Science Technology"},{"issue":"7\u20138","key":"3313_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.drudis.2010.02.009","volume":"16","author":"H Chen","year":"2011","unstructured":"Chen, H. (2011). Nanonization strategies for poorly water-soluble drugs. Drug Discovery Today,16(7\u20138), 354\u2013360.","journal-title":"Drug Discovery Today"},{"key":"3313_CR6","first-page":"2014","volume":"12","author":"C Chen","year":"2014","unstructured":"Chen, C. (2014). The citespace manual. Retrieved Octubre,12, 2014.","journal-title":"Retrieved Octubre"},{"issue":"15","key":"3313_CR7","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.vaccine.2015.02.046","volume":"33","author":"B Chen","year":"2015","unstructured":"Chen, B., & Zhang, J. M. (2015). Media and public reactions toward vaccination during the \u2018hepatitis B vaccine crisis\u2019 in China. Vaccine,33(15), 1780\u20131785.","journal-title":"Vaccine"},{"issue":"9","key":"3313_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1359-6446(00)01543-9","volume":"5","author":"P Dean","year":"2000","unstructured":"Dean, P. (2000). Building relationships between academia and the pharmaceutical industry. Drug Discovery Today,5(9), 377\u2013378.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"3313_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.295.1.90","volume":"295","author":"E Garfield","year":"2006","unstructured":"Garfield, E. (2006). The history and meaning of the journal impact factor. JAMA,295(1), 90\u201393.","journal-title":"JAMA"},{"key":"3313_CR10","first-page":"57","volume":"6","author":"C Giliyar","year":"2006","unstructured":"Giliyar, C. (2006). Challenges and opportunities in oral delivery of poorly water-soluble drugs. Drug Delivery Technologies,6, 57\u201363.","journal-title":"Drug Delivery Technologies"},{"issue":"4","key":"3313_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1517\/17425241003596337","volume":"7","author":"C-X He","year":"2010","unstructured":"He, C.-X. (2010). Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs. Expert Opinion on Drug Delivery,7(4), 445\u2013460.","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"8","key":"3313_CR12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/pds.1437","volume":"16","author":"Y Jing","year":"2007","unstructured":"Jing, Y., & Kelton, C. M. (2007). Lethal drug probe in China: The case of Xinfu clindamycin. Pharmacoepidemiology Drug and Safety,16(8), 928\u2013932.","journal-title":"Pharmacoepidemiology Drug and Safety"},{"issue":"3","key":"3313_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.ajkd.2009.10.055","volume":"55","author":"M-N Lai","year":"2010","unstructured":"Lai, M.-N., & Lai, J.-N. (2010). Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: A population-based case\u2013control study. American Journal of Kidney Diseases,55(3), 507\u2013518.","journal-title":"American Journal of Kidney Diseases"},{"key":"3313_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski, C. A. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews,64, 4\u201317.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"3313_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12939-016-0393-x","volume":"15","author":"Z Lulin","year":"2016","unstructured":"Lulin, Z. (2016). The effect of herd formation among healthcare investors on health sector growth in China. International Journal for Equity in Health,15(1), 113.","journal-title":"International Journal for Equity in Health"},{"issue":"4","key":"3313_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0928-0987(01)00098-7","volume":"12","author":"KG Mooney","year":"2001","unstructured":"Mooney, K. G. (2001). Challenges faced by the pharmaceutical industry: Training graduates for employment in pharmaceutical R&D. European Journal of Pharmaceutical Sciences,12(4), 353\u2013359.","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"12","key":"3313_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer, D. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology,2(12), 751.","journal-title":"Nature Nanotechnology"},{"key":"3313_CR18","first-page":"14","volume":"2012","author":"S Sethi","year":"2019","unstructured":"Sethi, S. (2019). Indian pharmaceutical industry: Learning to crawl before it runs. Symbiosis,2012, 14.","journal-title":"Symbiosis"},{"issue":"4","key":"3313_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1057\/abm.2009.15","volume":"8","author":"P Shapira","year":"2009","unstructured":"Shapira, P. (2009). From lab to market? Strategies and issues in the commercialization of nanotechnology in China. Journal of Asian Business Management,8(4), 461\u2013489.","journal-title":"Journal of Asian Business Management"},{"issue":"2","key":"3313_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/publications4020009","volume":"4","author":"M Tian","year":"2016","unstructured":"Tian, M., Su, Y., & Ru, X. (2016). Perish or publish in China: Pressures on young Chinese scholars to publish in internationally indexed journals. Publications,4(2), 9.","journal-title":"Publications"},{"issue":"44","key":"3313_CR21","first-page":"35","volume":"2010","author":"J Wang","year":"2010","unstructured":"Wang, J., & Chen, L.-Y. (2010). Demonstration of suspicious drugs in the methotrexate adverse drug event. China Pharmacy,2010(44), 35.","journal-title":"China Pharmacy"},{"issue":"1","key":"3313_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1108\/15587890680001301","volume":"1","author":"X Wu","year":"2006","unstructured":"Wu, X. (2006). The transformation of biomedical industry in China: From academic affair to commercialization. Journal of Asia Business Studies,1(1), 16\u201325.","journal-title":"Journal of Asia Business Studies"},{"issue":"1","key":"3313_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1756-5391.2010.01056.x","volume":"3","author":"T Wu","year":"2010","unstructured":"Wu, T., et al. (2010). Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine. Journal of Evidence-Based Medicine,3(1), 11\u201317.","journal-title":"Journal of Evidence-Based Medicine"},{"issue":"16","key":"3313_CR24","first-page":"2161","volume":"27","author":"M Xiao","year":"2016","unstructured":"Xiao, M., & Yingying, L. (2016). Discussion on the supervision problems and suggestions in the case of shandong vaccine. China Pharmacy,27(16), 2161\u20132163.","journal-title":"China Pharmacy"},{"issue":"10145","key":"3313_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0140-6736(18)31725-2","volume":"392","author":"X Yuan","year":"2018","unstructured":"Yuan, X. (2018). China\u2019s vaccine production scare. The Lancet,392(10145), 371.","journal-title":"The Lancet"},{"issue":"4","key":"3313_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jtcme.2014.12.003","volume":"5","author":"Q Zhan","year":"2015","unstructured":"Zhan, Q. (2015). Literature analysis of acanthopanax anaphylactic shock in China. Journal of Traditional Complementary Medicine,5(4), 253\u2013257.","journal-title":"Journal of Traditional Complementary Medicine"},{"key":"3313_CR27","unstructured":"Zhang, M. (2012). Who will defend chinese dining tables\u2014A review of Chinese Food Safety Law after the Sanlu milk scandal. Chinese Law Food Safety Milk Powder Scandals Food Industry."},{"issue":"8","key":"3313_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.drudis.2017.05.012","volume":"22","author":"W Zhang","year":"2017","unstructured":"Zhang, W., & Zhao, Q. (2017). Big data analysis of global advances in pharmaceutics and drug delivery 1980\u20132014. Drug Discovery Today,22(8), 1201\u20131208.","journal-title":"Drug Discovery Today"},{"issue":"4","key":"3313_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/pharmaceutics10040263","volume":"10","author":"H Zhong","year":"2018","unstructured":"Zhong, H., et al. (2018). A comprehensive map of FDA-approved pharmaceutical products. Pharmaceutics,10(4), 263.","journal-title":"Pharmaceutics"}],"container-title":["Scientometrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11192-019-03313-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11192-019-03313-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11192-019-03313-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:23:01Z","timestamp":1606954981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11192-019-03313-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["3313"],"URL":"https:\/\/doi.org\/10.1007\/s11192-019-03313-7","relation":{},"ISSN":["0138-9130","1588-2861"],"issn-type":[{"type":"print","value":"0138-9130"},{"type":"electronic","value":"1588-2861"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"22 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}